-
Baicalein incorporated nanoliposome disaggregates alpha-synuclein fibrils
-
Balance training modulates the concentration of pro- and anti-inflammatory cytokines in the plasma of elder people and PD patients. A pilot study
-
Baseline analysis of PROSPECT-M-UK: a longitudinal study of PSP, CBS and MSA
-
Baseline hyposmia and RBD symptoms are associated with faster, but differential, cognitive decline at 2 years in the PPMI study
-
BeaT-PD, An Industry-Academic Collaboration to Understand PD Progression in Ashkenazi Jews
-
BeatPark: a new wearable device for gait auto-rehabilitation in Parkinson’s disease delivering adapted musical stimulation.
-
Behavioural aspect of transgenic Drosophila melanogaster as a model of Parkinson’s disease treated by Ropinirole alginate nanocomposite
-
Beliefs, Knowledge and Attitudes Towards Parkinson’s Disease: Turkey Experience from a Global Perspective
-
Beneficial and protective effects of Terminalia chebula in a murine model of Parkinson’s disease
-
Beneficial effect of 36-month bilateral subthalamic stimulation on quality of sleep compared to standard-of-care medication in Parkinson’s disease
-
Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson’s disease
-
Benefit and Weakness with botulinum toxin: time course and relationship.
-
Benign hereditary chorea: A Tunisian family case presentation
-
Beyond the Periphery: Central Auditory Processing in Parkinsonian Disorders
-
Biallelic ZNF142-null mutations in patients with early-onset generalized dystonia
-
Bilateral Globus Pallidum interna stimulation for Blepharospasm
-
Bilateral Globus pallidus interna Deep Brain Stimulation in Cranio-Cervical Dystonia (Meige syndrome) patient in Hong Kong
-
Bilateral Globus pallidus internus deep brain stimulation as rescue therapy for ineffective subthalamic stimulation
-
Bilateral INO in PSP
-
Bilateral Putaminal AAV2-GDNF Delivery the Treatment of Advanced Parkinson’s Disease
-
Bilateral STN-DBS after bilateral pallidotomy for Parkinson’s disease: A Case Report
-
Bilateral vestibulopathy due to neurosarcoidosis mimicking Parkinsonian syndrome
-
Biomarkers of idiopathic REM sleep behavior disorder versus RBD within narcolepsy
-
Biomarkers of the Level of Cognitive Impairment (CI) in patients with Parkinson’s Disease (PD): MRS study
-
Biphasic Dyskinesias in Parkinson’s disease Patients treated with Levodopa/Carbidopa Intestinal Gel: Insights from a Multicenter Retrospective Analysis
-
Bladder Training for Urinary Tract Symptoms in PD – A Randomised Controlled Trial
-
Blood brain barrier dysfunction cause idiopathic adult onset ventriculomegaly?
-
Blood Metagenomics Analyses of Brazilian Parkinson’s Disease Patients: A Clinical Substype Study
-
Blood–brain barrier breakdown in an adult mouse model of Parkinson’s disease
-
Blue light therapy glasses in Parkinson’s disease: patients’ experience and effectiveness
-
BODILY AND FACIAL EMOTION RECOGNITION IN PARKINSON´S DISEASE
-
Body Mass Gain in Parkinson’s Disease Following Deep Brain Stimulation: A Systematic Review
-
Body Representation Impairments in Parkinson’s disease: A Preliminary Report
-
Botulinum Neurotoxin (BoNT) treatment in functional movement disorders: an extended follow up
-
Botulinum toxin content and activity: Potential implications for duration of efficacy in patients with cervical dystonia
-
Botulinum toxin for the management of dystonic scoliosis in children
-
Botulinum toxin injections reduce the symptoms of dystonic tremor and improve sensorimotor function for hand dexterity
-
Botulinum toxin treatment of muscle spasms in a case of Satoyoshi syndrome
-
Botulinum toxin type A therapy in a movement disorders unit: a 23-year experience.
-
BouNDless: An active-controlled randomized, double-blind double-dummy study of continuous ND0612 infusion in patients with fluctuating Parkinson’s disease
-
Braak model in Parkinson disease using MRI biomarkers
-
Brain amyloid contribution to cognitive dysfunction in Lewy bodies disorders: a pilot study
-
Brain and spinal cord structural alterations in non-ataxic and ataxic SCA3 mutation carriers
-
Brain MRI Volume Changes after 12 months laquinimod treatment of Huntington disease (LEGATO-HD)
-
Brain MRI-based discrimination between multiple system atrophy type cerebellar from other late onset sporadic cerebellar ataxias: a prospective study with implications for diagnosis criteria
-
Brain neurotransmitters and neuropeptides alternations in Parkinson’s induced mouse models
-
BST1 rs4698412 allelic variant increases the risk of gait or balance deficits in patients with Parkinson’s disease
-
Bumetanide to treat Parkinson’s disease patients suffering from freezing of gait resistant to both dopamine replacement treatment and subthalamic deep brain stimulation: an open-label pilot study (BumFOG)
-
Burden of Huntington’s disease in the US: Analysis of an insured population
2019 International Congress
September 22-26, 2019. Nice, France.